[The clinico-laboratory evaluation of the efficacy of Ciprobai and Cifran in treating the exacerbations of chronic pyelonephritis in patients with urolithiasis].
Savitskaia
K I
KI
Trapeznikova
M F
MF
Dutov
V V
VV
Nekhorosheva
A G
AG
Nasonov
V N
VN
Skala
L Z
LZ
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001682:Biological Availability; D002908:Chronic Disease; D002939:Ciprofloxacin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011704:Pyelonephritis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D013607:Tablets; D013997:Time Factors; D014545:Urinary Calculi / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D013607:Tablets; D002939:Ciprofloxacin
Kliniko-laboratornaia otsenka éffektivnosti tsiprobaia i tsifrana pri lechenii obostreniĭ khronicheskogo pielonefrita u bol'nykh mochekamennoĭ bolezn'iu.